Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
WOCKPHARMA | NSE
42.60
3.03%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
22/04/2026
1,450.30
1,410.00
1,456.10
1,405.00
Wockhardt Limited a pharmaceutical and biotechnology company manufactures and markets active pharmaceutical ingredients formulations bio-similars and vaccines in India the United States the United Kingdom Ireland Mexico Russia and internationally. It develops various molecules primarily in the areas of infectious diseases such as WCK 5222 WCK 4282 WCK 4873 WCK 771 and WCK 2349 and WCK 6777 molecules. The company's biopharmaceutical products include Glaritus an insulin analog; Wosulin an r-DNA insulin; Wepox a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B a hepatitis B vaccine. It also provides contract manufacturing services for sterile injectables lyophilization and other dosage forms; and research services. The company was founded in 1967 and is headquartered in Mumbai India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.
View LessPositive Momentum
Strong Revenue Growth (> 10%)
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
28.3%1 month
47.7%3 months
40.2%6 months
48.7%-
-
4.82
0.70
0.31
90.65
6.26
-
2.08B
222.51B
2.37B
-
5.14
840.60
14.80
-12.89
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
149.10
Range1M
369.90
Range3M
376.30
Rel. volume
0.87
Price X volume
1.02B
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Neuland Laboratories Limited | NEULANDLAB | Drug Manufacturers-Specialty & Generic | 15067 | 211.56B | 0.99% | 53.76 | 7.44% |
| AstraZeneca Pharma India Limited | ASTRAZEN | Drug Manufacturers-Specialty & Generic | 8440 | 211.00B | -0.14% | 197.18 | 0.65% |
| Piramal Pharma Limited | PPLPHARMA | Biotechnology | 153.81 | 203.34B | 1.99% | 805.68 | 59.54% |
| Dr. Reddy's Laboratories Limited | DRREDDY | Drug Manufacturers-Specialty & Generic | 1217 | 202.74B | -0.29% | 20.23 | 10.41% |
| NATCO Pharma Limited | NATCOPHARM | Drug Manufacturers-Specialty & Generic | 1071 | 191.83B | 1.45% | 15.31 | 6.34% |
| Eris Lifesciences Limited | ERIS | Drug Manufacturers-Specialty & Generic | 1352.8 | 184.38B | -1.69% | 48.08 | 107.55% |
| Syngene International Limited | SYNGENE | Biotechnology | 435.95 | 174.90B | -1.96% | 71.45 | 13.66% |
| Granules India Limited | GRANULES | Drug Manufacturers-Specialty & Generic | 672.75 | 163.05B | 0.75% | 29.41 | 40.77% |
| Alembic Pharmaceuticals Limited | APLLTD | Drug Manufacturers-Specialty & Generic | 764.6 | 153.21B | 0.04% | 36.23 | 10.65% |
| Jubilant Pharmova Limited | JUBLPHARMA | Drug Manufacturers-Specialty & Generic | 927.95 | 144.86B | 2.32% | 33.46 | 67.43% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| AFFLE | AFFLE | Advertising Agencies | 1446.4 | 202.28B | -1.13% | 67.64 | 7.31% |
| Vedant Fashions Limited | MANYAVAR | Apparel Retail | 449.95 | 110.06B | -0.20% | 84.26 | 27.74% |
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 51.24 | 44.95B | 1.41% | 48.67 | 10.74% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 277.25 | 16.25B | 1.98% | 30.54 | 80.30% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 103.52 | 15.25B | 2.86% | 28.83 | 43.67% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 205.52 | 7.33B | 4.01% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 210.57 | 6.80B | -1.93% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 60.51 | 1.67B | -0.80% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 93.83 | 1.36B | 0.75% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 75.7 | 843.96M | 1.75% | 50.06 | 4.88% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 90.65 | 24.85 | Expensive |
| Ent. to Revenue | 6.26 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | 4.82 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 40.22 | 42.17 | Par |
| Debt to Equity | 0.70 | 0.35 | Expensive |
| Debt to Assets | 0.31 | 0.17 | Expensive |
| Market Cap | 222.51B | 290.82B | Emerging |